134 related articles for article (PubMed ID: 36254754)
1. Simplified hybrids of two anticancer bistetrahydroisoquinoline alkaloids ecteinascidin 743 and cribrostatin 4 and inhibitory activity against proliferation of cancer cells.
Wang M; Yu BB; Yao ZJ
Org Biomol Chem; 2022 Nov; 20(43):8438-8442. PubMed ID: 36254754
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxic evaluation of some cribrostatin-ecteinascidin analogues.
Wright BJ; Chan C; Danishefsky SJ
J Nat Prod; 2008 Mar; 71(3):409-14. PubMed ID: 18278868
[TBL] [Abstract][Full Text] [Related]
3. Development of Cyclic
Wang M; Wang T; Qin X; Yao ZJ
Org Lett; 2024 Mar; 26(9):1764-1769. PubMed ID: 38407113
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxicity of a novel series of saframycin-ecteinascidin analogs containing tetrahydro-β-carboline moieties.
Lu X; Pan X; Yang Y; Ji M; Chen X; Xiao Z; Liu Z
Eur J Med Chem; 2017 Jul; 135():260-269. PubMed ID: 28456034
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the synthesis and activity of analogues of bistetrahydroisoquinoline alkaloids as antitumor agents.
Guo J
Eur J Med Chem; 2023 Dec; 262():115917. PubMed ID: 37925762
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of simplified tetrahydroisoquinoline analogs.
Yang Y; Gao Y; Chen S; Guo J; Hu Y
Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300453. PubMed ID: 37814371
[TBL] [Abstract][Full Text] [Related]
7. A novel tetrahydroisoquinoline (THIQ) analogue induces mitochondria-dependent apoptosis.
Sun X; Liu M; Gao L; Mao Y; Zhao D; Zhuang J; Liu L
Eur J Med Chem; 2018 Apr; 150():719-728. PubMed ID: 29573707
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.
Rane RA; Sahu NU; Gutte SD; Mahajan AA; Shah CP; Bangalore P
Eur J Med Chem; 2013 May; 63():793-9. PubMed ID: 23584542
[TBL] [Abstract][Full Text] [Related]
9. Renieramycin J, a highly cytotoxic tetrahydroisoquinoline alkaloid, from a marine sponge Neopetrosia sp.
Oku N; Matsunaga S; van Soest RW; Fusetani N
J Nat Prod; 2003 Aug; 66(8):1136-9. PubMed ID: 12932144
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G.
Lane JW; Estevez A; Mortara K; Callan O; Spencer JR; Williams RM
Bioorg Med Chem Lett; 2006 Jun; 16(12):3180-3. PubMed ID: 16632360
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-κB signaling pathway.
Sim S; Lee S; Ko S; Phuong Bui B; Linh Nguyen P; Cho J; Lee K; Kang JS; Jung JK; Lee H
Bioorg Med Chem; 2021 Sep; 46():116371. PubMed ID: 34500188
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxicity of 3-aryl acrylic amide derivatives of the simplified saframycin-ecteinascidin skeleton prepared from L-dopa.
Guo J; Dong W; Liu W; Yan Z; Wang N; Liu Z
Eur J Med Chem; 2013 Apr; 62():670-6. PubMed ID: 23434640
[TBL] [Abstract][Full Text] [Related]
13. Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.
Le VH; Inai M; Williams RM; Kan T
Nat Prod Rep; 2015 Feb; 32(2):328-47. PubMed ID: 25273374
[TBL] [Abstract][Full Text] [Related]
14. Development of tetrahydroisoquinoline-based hydroxamic acid derivatives: potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities.
Zhang Y; Feng J; Jia Y; Wang X; Zhang L; Liu C; Fang H; Xu W
J Med Chem; 2011 Apr; 54(8):2823-38. PubMed ID: 21476600
[TBL] [Abstract][Full Text] [Related]
15. Renieramycin-type alkaloids from marine-derived organisms: Synthetic chemistry, biological activity and structural modification.
Fang Y; Li H; Ji B; Cheng K; Wu B; Li Z; Zheng C; Hua H; Li D
Eur J Med Chem; 2021 Jan; 210():113092. PubMed ID: 33333398
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and inhibition of cancer cell proliferation of (1,3')-bis-tetrahydroisoquinolines and piperazine systems.
Aubry S; Pellet-Rostaing S; Fournier Dit Chabert J; Ducki S; Lemaire M
Bioorg Med Chem Lett; 2007 May; 17(9):2598-602. PubMed ID: 17317166
[TBL] [Abstract][Full Text] [Related]
17. Advances in the 1-phenanthryl-tetrahydroisoquinoline series of PAK4 inhibitors: potent agents restrain tumor cell growth and invasion.
Hao C; Li X; Song S; Guo B; Guo J; Zhang J; Zhang Q; Huang W; Wang J; Lin B; Cheng M; Li F; Zhao D
Org Biomol Chem; 2016 Aug; 14(32):7676-90. PubMed ID: 27454186
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Cytotoxic Activity of Novel Mono- and Bis-Indole Derivatives: Analogues of Marine Alkaloid Nortopsentin.
Kamel MM; Abdel-Hameid MK; El-Nassan HB; El-Khouly EA
Med Chem; 2021; 17(7):779-789. PubMed ID: 32386499
[TBL] [Abstract][Full Text] [Related]
19. (±)-trans-Dihydronarciclasine and (±)-trans-dihydrolycoricidine analogues modified in their ring A: Evaluation of their anticancer activity and a SAR study.
Varró G; Pálchuber P; Pogrányi B; Simon A; Hegedűs L; Kádas I
Eur J Med Chem; 2019 Jul; 173():76-89. PubMed ID: 30986573
[TBL] [Abstract][Full Text] [Related]
20. Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.
Drugs R D; 2006; 7(5):317-28. PubMed ID: 16922593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
